Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma | Zendy

Takeshi Terashima | Zendy; Chigusa Morizane | Zendy; Nobuyoshi Hiraoka | Zendy; Hitoshi Tsuda | Zendy; Tomohiko Tamura | Zendy; Yoshifumi Shimada | Zendy; Satoshi Kaneko | Zendy; Ryoji Kushima | Zendy; Hideki Ueno | Zendy; Shunsuke Kondo | Zendy; M. Ikeda | Zendy; Takuji Okusaka | Zendy

Open Access

Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma

Author(s) -

Takeshi Terashima,

Chigusa Morizane,

Nobuyoshi Hiraoka,

Hitoshi Tsuda,

Tomohiko Tamura,

Yoshifumi Shimada,

Satoshi Kaneko,

Ryoji Kushima,

Hideki Ueno,

Shunsuke Kondo,

M. Ikeda,

Takuji Okusaka

Publication year - 2012

Publication title -

neuroendocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.493

H-Index - 101

eISSN - 1423-0194

pISSN - 0028-3835

DOI - 10.1159/000338794

Subject(s) - medicine , gastroenterology , group b , chemotherapy , neuroendocrine tumors , carcinoma , small cell carcinoma , lung , group a , gastrointestinal tract , regimen

The chemotherapy for small-cell lung carcinoma (SCLC) has been adopted for advanced extrapulmonary neuroendocrine carcinomas (EP-NECs). The aim of this study was to clarify the efficacy of standard SCLC regimens when used to treat EP-NECs and to compare the outcome with that for SCLC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research